Veliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of Medulloblastoma
出版年份 2021 全文链接
标题
Veliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of Medulloblastoma
作者
关键词
-
出版物
Frontiers in Molecular Biosciences
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-04-29
DOI
10.3389/fmolb.2021.633344
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma
- (2021) Raelene Endersby et al. Science Translational Medicine
- Assessment of Cannabidiol and Δ9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma
- (2021) Clara Andradas et al. Cancers
- Clinical use and mechanisms of resistance for PARP inhibitors in homologous recombination-deficient cancers
- (2021) Dawn C. Janysek et al. Translational Oncology
- A Phase I/II Study of Veliparib (ABT-888) with Radiation and Temozolomide in Newly Diagnosed Diffuse Pontine Glioma: A Pediatric Brain Tumor Consortium Study
- (2020) P A Baxter et al. NEURO-ONCOLOGY
- Tumor mutational burden and driver mutations: Characterizing the genomic landscape of pediatric brain tumors
- (2020) Roshal R. Patel et al. PEDIATRIC BLOOD & CANCER
- Medulloblastoma
- (2019) Paul A. Northcott et al. Nature Reviews Disease Primers
- Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocol
- (2019) Masatoshi Takagi et al. BMC Pediatrics
- Commissioning and performance characteristics of a pre-clinical image-guided radiotherapy system
- (2019) Theresa V. Feddersen et al. AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE
- Towards Immunotherapy for Pediatric Brain Tumors
- (2019) Stacie Shiqi Wang et al. TRENDS IN IMMUNOLOGY
- Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2‐Year Durable Response
- (2019) Andge Valiakhmetova et al. ONCOLOGIST
- Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411)
- (2019) Eric S. Schafer et al. PEDIATRIC BLOOD & CANCER
- The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers
- (2019) Tatiana Kamaletdinova et al. Cells
- Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma
- (2017) Toni Rose Jue et al. Journal of Translational Medicine
- Restricted Delivery of Talazoparib Across the Blood–Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma
- (2017) Sani H. Kizilbash et al. MOLECULAR CANCER THERAPEUTICS
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Combenefit: an interactive platform for the analysis and visualization of drug combinations
- (2016) Giovanni Y. Di Veroli et al. BIOINFORMATICS
- Medulloblastoma
- (2016) Nathan E. Millard et al. JOURNAL OF CHILD NEUROLOGY
- Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
- (2016) Y. Pommier et al. Science Translational Medicine
- Delineation ofMGMTHypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma
- (2015) Shiv K. Gupta et al. JNCI-Journal of the National Cancer Institute
- Poly-ADP-Ribose Polymerase as a Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma and Pediatric High-Grade Astrocytoma
- (2015) Y. Chornenkyy et al. MOLECULAR CANCER THERAPEUTICS
- Delineation ofMGMTHypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma
- (2015) Shiv K. Gupta et al. JNCI-Journal of the National Cancer Institute
- PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation
- (2015) Dannis Gilbert Van Vuurden et al. Oncotarget
- Management of Pediatric and Adult Patients with Medulloblastoma
- (2014) Allison M. Martin et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a Pediatric Brain Tumor Consortium report†
- (2014) Jack M. Su et al. NEURO-ONCOLOGY
- OpenComet: An automated tool for comet assay image analysis
- (2014) Benjamin M. Gyori et al. Redox Biology
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- Systematic identification of synergistic drug pairs targeting HIV
- (2012) Xu Tan et al. NATURE BIOTECHNOLOGY
- Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699
- (2010) R A Daniel et al. BRITISH JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now